Meadowhawk Biolabs, Inc.
Golam Mezbah Uddin, Ph.D. is a Principal Scientist at Meadowhawk Biolabs, Inc. where Golam Mezbah provides in vivo pharmacology expertise to biotech/pharmaceuticals during their development phases. Prior to this role, Golam Mezbah worked as a Postdoctoral Associate at the University of Calgary and the University of Alberta, where Golam Mezbah investigated molecular pathways related to age-related mitochondrial disease, diabetic cardiomyopathy, and heart failure. Golam Mezbah also has experience as a Research Assistant at UNSW, performing molecular experiments on animal tissues. Golam Mezbah Uddin holds a PhD in Physiology and Pharmacology from UNSW, a MS in Pharmaceutical Sciences from Korea Institute of Science and Technology, and a BPharm from Stamford University Bangladesh.
Meadowhawk Biolabs, Inc.
Meadowhawk biolabs is a CRO that was created to make a difference for our pharmaceutical and biotech clients in drug discovery and development. Our curiosity, unwillingness to accept the status quo and unflagging commitment and alignment to our values drives us to partner with our clients to bring new treatments and therapeutics faster to patients.